Microalbuminuria and cardiovascular disease

Area of Science:

• Nephrology
• Cardiology
• Vascular Biology

Background:

• Cardiovascular disease (CVD) management increasingly emphasizes preventive strategies.
• Microalbuminuria is recognized as a marker of an atherogenic state.
• It is independently predictive of mortality and CVD events in various populations.

Purpose of the Study:

• To review the role of microalbuminuria in cardiovascular risk assessment.
• To explore the pathophysiologic links between albuminuria and CVD.
• To discuss the implications for screening and intervention strategies.

Main Methods:

• Review of prospective and epidemiologic studies.
• Analysis of pathophysiologic hypotheses linking microalbuminuria to CVD.
• Examination of intervention study data.

Main Results:

• Microalbuminuria predicts all-cause and cardiovascular mortality and CVD events.
• It may indicate subclinical vascular damage and systemic endothelial dysfunction.
• Intervention studies show benefits from ACE inhibitors, ARBs, statins, and glycemic control.

Conclusions:

• Periodic screening for microalbuminuria aids early identification of vascular disease.
• A positive test warrants intensive multifactorial interventions.
• This marker can optimize secondary prevention strategies for CVD.